Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China.

Elife · 2023 · PMC10110235 · PMID 36928099

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

In addition, a significant trend of declining S-antibody levels was observed following AstraZeneca ChAdOx1 and BNT162b2 administration, with levels reducing by about 5-fold and 2-fold 21–41 days and 70 days or more after the second dose, respectively ( Shrotri et al., 2021 ).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.